SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 15-16, 2001, Pages 2118-2126

Potency of clinical group B streptococcal conjugate vaccines

a BRIGHAM AND WOMEN S HOSPITAL (United States)

Author keywords

Exclusion criteria; Glycoconjugates; Group B streptococci; Maternal vaccination; Neonatal infections; Perinatal infections; Potency; Stability; Women's health

Indexed keywords

BACTERIAL POLYSACCHARIDE; STREPTOCOCCUS AGALACTIAE CAPSULAR POLYSACCHARIDE PROTEIN CONJUGATE VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG FORMULATION; DRUG POTENCY; DRUG STORAGE; FEMALE; FREEZE DRYING; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ANIMALS; ANIMALS, NEWBORN; ANIMALS, OUTBRED STRAINS; DRUG STABILITY; FEMALE; FREEZE DRYING; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; MICE; POLYSACCHARIDES, BACTERIAL; PREGNANCY; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 0035961562 PISSN: 0264410X EISSN: None Source Type: Journal
DOI: 10.1016/S0264-410X(00)00437-0 Document Type: Article

Times cited : (18)

References (17)

1
- 0034610804
- Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
- (2000) N Engl J Med , vol.342 , pp. 15-20
- Schrag, S.J.¹ Zywicki, S.² Farley, M.M.³ Reingold, A.L.⁴ Harrison, L.H.⁵ Lefkowitz, L.B.⁶ Hadler, J.L.⁷ Danila, R.⁸ Cieslak, P.R.⁹ Schuchat, A.¹⁰

2
- 0025133419
- Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus
- (1990) J Clin Invest , vol.86 , pp. 1428-1433
- Wessels, M.R.¹ Paoletti, L.C.² Kasper, D.L.³ DiFabio, J.L.⁴ Michon, F.⁵ Holme, K.⁶ Jennings, H.J.⁷

3
- 0027432395
- Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine
- (1993) Infect Immun , vol.61 , pp. 4760-4766
- Wessels, M.R.¹ Paoletti, L.C.² Rodewald, A.K.³ Michon, F.⁴ DiFabio, J.⁵ Jennings, H.J.⁶ Kasper, D.L.⁷

4
- 0028947032
- Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine
- (1995) J Infect Dis , vol.171 , pp. 879-884
- Wessels, M.R.¹ Paoletti, L.C.² Pinel, J.³ Kasper, D.L.⁴

5
- 0026768039
- Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine
- (1992) Infect Immun , vol.60 , pp. 4009-4014
- Paoletti, L.C.¹ Wessels, M.R.² Michon, F.³ DiFabio, J.⁴ Jennings, H.J.⁵ Kasper, D.L.⁶

6
- 0032929596
- Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib
- (1999) J Infect Dis , vol.179 , pp. 142-150
- Baker, C.J.¹ Paoletti, L.C.² Wessels, M.R.³ Guttormsen, H.-K.⁴ Rench, M.A.⁵ Hickman, M.E.⁶ Kasper, D.L.⁷

7
- 0033796003
- Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women
- in press
- (2000) J Infect Dis
- Baker, C.J.¹ Paoletti, L.C.² Rench, M.A.³ Guttormsen, H.-K.⁴ Carey, V.J.⁵ Hickman, M.E.⁶ Kasper, D.L.⁷

8
- 0029852095
- Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine
- (1996) J Clin Invest , vol.98 , pp. 2308-2314
- Kasper, D.L.¹ Paoletti, L.C.² Wessels, M.R.³ Guttormsen, H.K.⁴ Carey, V.J.⁵ Jennings, H.J.⁶ Baker, C.J.⁷

9
- 0003308940
- Neonatal group B streptococcal disease: Progress towards a multivalent maternal vaccine
- Washington, DC; Abstr. P.16
- (1998) The First Annual Conference on Vaccine Research
- Paoletti, L.C.¹ Baker, C.J.² Kasper, D.L.³

10
- 0028306125
- Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes
- (1994) J Clin Invest , vol.94 , pp. 286-292
- Madoff, L.C.¹ Paoletti, L.C.² Tai, J.Y.³ Kasper, D.L.⁴

11
- 0026709312
- Neonatal mouse model of group B streptococcal infection
- (1992) J Infect Dis , vol.166 , pp. 635-639
- Rodewald, A.K.¹ Onderdonk, A.B.² Warren, H.B.³ Kasper, D.L.⁴

12
- 0030900796
- Therapeutic potential of human antisera to group B streptococcal glycoconjugate vaccines in neonatal mice
- (1997) J Infect Dis , vol.175 , pp. 1237-1239
- Paoletti, L.C.¹ Pinel, J.² Rodewald, A.K.³ Kasper, D.L.⁴

13
- 33745158157
- A simple method of estimating fifty per cent endpoints
- (1938) Amer J Hygiene , vol.27 , pp. 493-497
- Reed, L.J.¹ Muench, H.²

14
- 0025037817
- Synthesis and immunological properties of conjugates composed of group B Streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid
- (1990) Infect Immun , vol.58 , pp. 687-694
- Lagergard, T.¹ Shiloach, J.² Robbins, J.B.³ Schneerson, R.⁴

15
- 0032845860
- Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII
- (1999) J Infect Dis , vol.180 , pp. 892-895
- Paoletti, L.C.¹ Pinel, J.² Johnson, K.D.³ Reinap, B.⁴ Ross, R.A.⁵ Kasper, D.L.⁶

16
- 0034049542
- Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate
- (2000) J Infect Dis , vol.181 , pp. 653-658
- Paoletti, L.C.¹ Pinel, J.² Kennedy, R.C.³ Kasper, D.L.⁴

17
- 0030033274
- Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons
- (1996) Infect Immun , vol.64 , pp. 677-679
- Paoletti, L.C.¹ Kennedy, R.C.² Chanh, T.C.³ Kasper, D.L.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.